SEPTIN4 and acute lymphoblastic leukemia: ARTS expression is lost in more than 70% of acute lymphoblastic leukemia (ALL) patients [51], in 50% of lymphoma patients [85], and in a significant fraction of hepatocellular carcinoma (HCC) patients.